Dr Roger Paterson shares a research update from two International ADHD conferences in Tel Aviv, Isreal and Madrid, Spain.

About Dr Roger Paterson

Roger Paterson, MB BS, FRCPsych, FRANZCP, Cert. Child & Adolescent Consultant Psychiatrist in full-time private practice. He has been active in the field of child, adolescent and adult ADHD for more than two decades.

Roger been a member of the WA Stimulants Committee and continues to advocate for the multimodal treatment of ADHD within the public and private sectors, for all age groups. He is the published principal author of a world first study showing that dexamphetamine was useful in the treatment of adult ADHD, a long-standing member of the ADHD WA Professional Advisory Board for 22 years, and is a board member of the Australian ADHD Professionals Association (AADPA).

Roger Paterson - AAPDA Board Member

Our mission at AADPA is to promote evidence-based research, diagnosis, treatment & management of ADHD for the benefit of Australians with ADHD & their families.

About AADPA

We are committed to working towards enhanced lifetime outcomes for individuals with ADHD and their families.

Member Benefits

Gain resources, support and guidance from Australia’s leading professional ADHD community.

Membership Types

Our members come from a range of fields including academia, clinical practice, coaching, education and allied healthcare.